Mechanisms that Promote and Suppress Chromosomal Translocations in Lymphocytes

被引:118
作者
Gostissa, Monica [1 ,2 ,3 ]
Alt, Frederick W. [1 ,2 ,3 ]
Chiarle, Roberto [1 ,2 ,3 ,4 ,5 ]
机构
[1] Childrens Hosp Boston, Howard Hughes Med Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[4] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy
[5] Univ Turin, CERMS, I-10126 Turin, Italy
来源
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 | 2011年 / 29卷
关键词
antigen receptor genes; DNA double-strand breaks; nonhomologous end-joining; DSB repair; lymphoma; DOUBLE-STRAND-BREAK; CLASS SWITCH RECOMBINATION; DNA-LIGASE-IV; END-JOINING PATHWAY; B-CELL; V(D)J RECOMBINATION; C-MYC; GENOMIC INSTABILITY; LYMPHOBLASTIC-LEUKEMIA; ATAXIA-TELANGIECTASIA;
D O I
10.1146/annurev-immunol-031210-101329
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recurrent chromosomal translocations are characteristic features of many types of cancers, especially lymphomas and leukemias. Several basic mechanistic factors are required for the generation of most translocations. First, DNA double-strand breaks (DSBs) must be present simultaneously at the two participating loci. Second, the two broken loci must either be in proximity or be moved into proximity to be joined. Finally, cellular DNA repair pathways must be available to join the two broken loci to complete the translocation. These mechanistic factors can vary in different normal and mutant cells and, as a result, substantially influence the frequency at which particular translocations are generated in a given cell type. Ultimately, however, appearance of recurrent oncogenic translocations in tumors is, in most cases, strongly influenced by selection for the translocated oncogene during the tumorigenesis process. In this review, we discuss in depth the factors and pathways that contribute to the generation of translocations in lymphocytes and other cell types. We also discuss recent findings regarding mechanisms that underlie the appearance of recurrent translocations in tumors.
引用
收藏
页码:319 / 350
页数:32
相关论文
共 176 条
[1]   Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system [J].
Agrawal, A ;
Eastman, QM ;
Schatz, DG .
NATURE, 1998, 394 (6695) :744-751
[2]   XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining [J].
Ahnesorg, P ;
Smith, P ;
Jackson, SP .
CELL, 2006, 124 (02) :301-313
[3]   Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice [J].
Akamatsu, Y ;
Monroe, R ;
Dudley, DD ;
Elkin, SK ;
Gärtner, F ;
Talukder, SR ;
Takahama, Y ;
Alt, FW ;
Bassing, CH ;
Oettinger, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :1209-1214
[4]   Common fragile sites as targets for chromosome rearrangements [J].
Arlt, Martin F. ;
Durkin, Sandra G. ;
Ragland, Ryan L. ;
Glover, Thomas W. .
DNA REPAIR, 2006, 5 (9-10) :1126-1135
[5]   Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains [J].
Aten, JA ;
Stap, J ;
Krawczyk, PM ;
van Oven, CH ;
Hoebe, RA ;
Essers, J ;
Kanaar, R .
SCIENCE, 2004, 303 (5654) :92-95
[6]   Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors [J].
Avet-Loiseau, H ;
Gerson, F ;
Magrangeas, F ;
Minvielle, S ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2001, 98 (10) :3082-3086
[7]   ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage [J].
Barzilai, A ;
Rotman, G ;
Shiloh, Y .
DNA REPAIR, 2002, 1 (01) :3-25
[8]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[9]   The cellular response to general and programmed DNA double strand breaks [J].
Bassing, CH ;
Alt, FW .
DNA REPAIR, 2004, 3 (8-9) :781-796
[10]   The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation [J].
Basu, U ;
Chaudhuri, J ;
Alpert, C ;
Dutt, S ;
Ranganath, S ;
Li, G ;
Schrum, JP ;
Manis, JP ;
Alt, FW .
NATURE, 2005, 438 (7067) :508-511